The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.
Dunkley
S M
SM
Yang
K
K
D000328:Adult; D000855:Anorexia / Q000150:complications*; D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D015942:Factor VIIa / Q000008:administration & dosage*; D005260:Female; D006467:Hemophilia A / Q000175:diagnosis* / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa